Callitas Health Enters into Exclusive Development and Intellectual Property Agreement for CannaMint Strips and Files Additional Trademarks for CannaStrips and CanRelief
24 mai 2018 08h30 HE
|
Callitas Health Inc.
CINCINNATI, OH, May 24, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and...
Callitas Health Signs Dr. Gregory Smith MD, MPH, as the Company's Chief Medical Cannabis Advisor
21 mai 2018 10h55 HE
|
Callitas Health Inc.
CINCINNATI, OH, May 21, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE:LILY) (OTCQB:MPHMF) (FWB:T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and...
Callitas Health Interim President & CEO Will Present at the 2018 Proactive's CEO Investors Forum
09 mai 2018 08h30 HE
|
Callitas Health Inc.
CINCINNATI, OH & NEW YORK, NY, May 09, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage...
Callitas Health, Inc. Releases Annual Update Letter to Shareholders
19 avr. 2018 09h46 HE
|
Callitas Health Inc.
CINCINNATI, OH, April 19, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2) today announced that Interim President and Chief Executive Officer, James Thompson, has...
Callitas Health, Inc. Signs Multiple Letters of Intent for Distribution of CannaMint Strips in California
16 avr. 2018 08h00 HE
|
Callitas Health Inc.
CINCINNATI, OH & LOS ANGELES, CA , April 16, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2), (the "Company" or “Callitas”) an integrated clinical-stage...
Callitas Health Announces Response from US FDA on Orphan Drug Designation and Rare Pediatric Disease Designation Requests
15 mars 2018 08h30 HE
|
Callitas Health Inc.
CINCINNATI, OH, March 15, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative...
UPDATE: Callitas Health Announces Selection of TraDigitalIR as Investor and Public Relations Advisor
15 mars 2018 06h00 HE
|
Callitas Health Inc.
CINCINNATI and NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative...
Callitas Health Announces Selection of TraDigitalIR as Investor and Public Relations Advisor
13 mars 2018 12h10 HE
|
Callitas Health Inc.
CINCINNATI and NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative...
Callitas Health, Inc Receives Notice of Allowance from USPTO for Patent Application for Treatment for Male Infertility and Sub-Fertility
08 mars 2018 18h17 HE
|
Callitas Health Inc.
CINCINNATI, OH , March 08, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative...
Callitas Health Inc., Announces New Partnership with NFI Consumer Healthcare's e.p.t. Pregnancy Test Line
05 mars 2018 11h27 HE
|
Callitas Health Inc.
CINCINNATI, OH, March 05, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative...